Regeneron will acquire 23andMe for $256 million


Several lawmakers and officials, including the Federal Trade Commission, had expressed concerns about the safety of consumers’ genetic data through 23andMe’s sale process. 

The privacy ombudsman will present a report on the acquisition to the court by June 10.

“We are pleased to have reached a transaction that maximizes the value of the business and enables the mission of 23andMe to live on, while maintaining critical protections around customer privacy, choice and consent with respect to their genetic data,” Mark Jensen, 23andMe’s board chair, said in a statement.


Comments

Popular posts from this blog

Hamza Chaudhry

Swarm 🦹‍♂️

Digital ID tracking system